FDA and Biotech
MIRM: FDA Approves ATEBRIOZ on November 3
The local catalyst feed records an FDA approval for Mirum's ATEBRIOZ and orphan drug designation for brelovitug on November 3. The entries concern separate drugs and indications.
TAG
biotech catalysts